An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.
In the last several years, United States market of Implantable Neurostimulators developed rapidly, with an average growth rate of 11%. In 2015, United States capacity of Implantable Neurostimulators is nearly 169 k units, the actual production is about 130 k units, and local sales are about 87 k units.
The global Implantable Neurostimulators market was valued at US$ 5385.1 million in 2019 and is expected to reach US$ 11410 million by the end of 2026, growing at a CAGR of 11.2% during 2021-2026.
This report focuses on Implantable Neurostimulators volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Implantable Neurostimulators market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Implantable Neurostimulators Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Deep Brain Stimulators
Spinal Cord Stimulators
Vagal Nerve Stimulators
Sacral Nerve Stimulators
Gastric Stimulators
Others
Segment by Application
Parkinson's Disease
Epilepsy
Pain
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic
Boston Scientific
Abbott
Cyberonics
NeuroPace
Synapse Biomedical
NeuroSigma
ReShape Lifesciences
ElectroCore Medical
Inspire Medical
NEUROS
SPR
IMTHERA
NEVRO
In the last several years, United States market of Implantable Neurostimulators developed rapidly, with an average growth rate of 11%. In 2015, United States capacity of Implantable Neurostimulators is nearly 169 k units, the actual production is about 130 k units, and local sales are about 87 k units.
The global Implantable Neurostimulators market was valued at US$ 5385.1 million in 2019 and is expected to reach US$ 11410 million by the end of 2026, growing at a CAGR of 11.2% during 2021-2026.
This report focuses on Implantable Neurostimulators volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Implantable Neurostimulators market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Implantable Neurostimulators Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Deep Brain Stimulators
Spinal Cord Stimulators
Vagal Nerve Stimulators
Sacral Nerve Stimulators
Gastric Stimulators
Others
Segment by Application
Parkinson's Disease
Epilepsy
Pain
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic
Boston Scientific
Abbott
Cyberonics
NeuroPace
Synapse Biomedical
NeuroSigma
ReShape Lifesciences
ElectroCore Medical
Inspire Medical
NEUROS
SPR
IMTHERA
NEVRO
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.